Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
PlexusDx's genetic and biomarker approach may help provide context on how your unique predispositions in peptide-response pathways could influence safety risk, supporting a more informed conversation with your healthcare provider
Vallieres, C., Holland, S
No customs hold-ups, no overseas delays, and no uncertainty about where your parcel is
That obsession doesn't stop when a product leaves our facility
Up to now, powerful genetic tools allowed clarification of the significance, dispensability and potential of cystine transporters for ferroptotic cell death in PDAC and breast cancer ( via xCT ( A high extracellular glutamate concentration was one of the first xCT inhibitors described but a few years later, erastin (standing for eradicator of RAS and small T antigen-expressing cells) was identified by Stockwell's group in RAS-mutated cancer cell lines as inhibitor of xCT transport ( in vitro studies as efficient inducer of ferroptosis in many different cancer types, including breast, PDAC, lymphoma, renal, brain and ovarian cancers ( via transsulfuration pathway is a potential resistance mechanism under cysteine depletion conditions
